Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Markets

Granules India rises on USFDA nod for oral drug Glycopyrrolate

Granules India added 1.77% to Rs 673.95 after the US Food and Drug Administration (FDA) approved its abbreviated new drug application (ANDA) for Glycopyrrolate Oral Solution.

By: business-standard.com

Aug 20 2024
3
12529 Views

Granules India rises on USFDA nod for oral drug Glycopyrrolate

Granules India rises on USFDA nod for oral drug Glycopyrrolate

Related

Macquarie reaffirms 'outperform' rank to TCS; stock hits 52-week high

Unimech Aerospace Ltd files draft papers with Sebi for Rs 500 cr IPO

Benchmark stocks to rise modestly by year-end, correction unlikely: Poll

Sebi releases new cyber security framework for regulated entities

Haryana-based Innovision files IPO papers with Sebi, eyes Rs 315 cr

Kharif crop sowing rises to 1031.56 lakh hectares

EPFO adds net 19.29 lakh members in June 2024

IPO fee pool to surpass 2023's total; Ola, FirstCry spell gains for bankers

Indices gain amidst fed rate cut optimism; IT, financial stocks lead

INR firm at over two-week high amid positive local equities

P I Industries completes acquisition of UK based Plant Health Care Plc

Board of Sansera Engineering approves fund raising up to Rs 1,200 cr

Macquarie reaffirms 'outperform' rank to TCS; stock hits 52-week high